A detailed history of Resources Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Resources Management Corp holds 59,082 shares of BMY stock, worth $2.39 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
59,082
Previous 63,471 6.91%
Holding current value
$2.39 Million
Previous $3.26 Million 1.63%
% of portfolio
0.47%
Previous 0.48%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $210,584 - $238,761
-4,389 Reduced 6.91%
59,082 $3.2 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $3.07 Million - $3.67 Million
63,420 Added 124352.94%
63,471 $3.26 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $3.28 Million - $3.91 Million
-67,570 Reduced 99.92%
51 $3.26 Million
Q3 2023

Nov 16, 2023

SELL
$57.89 - $64.73 $30,102 - $33,659
-520 Reduced 0.76%
67,621 $3.92 Million
Q2 2023

Aug 16, 2023

BUY
$63.71 - $70.74 $3.96 Million - $4.4 Million
62,179 Added 1042.92%
68,141 $4.36 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $4.14 Million - $4.7 Million
-63,039 Reduced 91.36%
5,962 $115,000
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $1,027 - $1,216
-15 Reduced 0.02%
69,001 $4.97 Million
Q3 2022

Nov 15, 2022

SELL
$0.13 - $76.84 $66 - $39,572
-515 Reduced 0.74%
69,016 $4.91 Million
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $33,913 - $37,350
-467 Reduced 0.67%
69,531 $5.35 Million
Q1 2022

May 20, 2022

SELL
$61.48 - $73.72 $451,570 - $541,473
-7,345 Reduced 9.5%
69,998 $5.11 Million
Q4 2021

Feb 04, 2022

SELL
$53.63 - $62.52 $475,644 - $554,489
-8,869 Reduced 10.29%
77,343 $4.82 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $120,351 - $140,976
-2,034 Reduced 2.3%
86,212 $5.1 Million
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $285,467 - $310,873
-4,611 Reduced 4.97%
88,246 $5.9 Million
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $182,351 - $205,092
-3,073 Reduced 3.2%
92,857 $5.86 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $185,865 - $210,619
-3,219 Reduced 3.25%
95,930 $5.95 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $2,354 - $2,609
41 Added 0.04%
99,149 $5.98 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $107,995 - $126,257
1,970 Added 2.03%
99,108 $5.83 Million
Q1 2020

May 04, 2020

SELL
$46.4 - $67.43 $167,272 - $243,085
-3,605 Reduced 3.58%
97,138 $5.41 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $1.77 Million - $2.3 Million
35,885 Added 55.33%
100,743 $6.47 Million
Q3 2019

Dec 04, 2019

SELL
$42.77 - $50.71 $66,763 - $79,158
-1,561 Reduced 2.35%
64,858 $3.29 Million
Q4 2018

Feb 21, 2019

SELL
$48.76 - $63.23 $217,177 - $281,626
-4,454 Reduced 6.28%
66,419 $3.45 Million
Q3 2018

Nov 15, 2018

BUY
$55.19 - $62.25 $3.91 Million - $4.41 Million
70,873 New
70,873 $4.4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Resources Management Corp Portfolio

Follow Resources Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Resources Management Corp with notifications on news.